heart failure
37% risk reduction for progression to symptomatic heart failure can be       achieved with ACE-inhibition in asymptomatic patients with systolic left       ventricular dysfunction (55).
37% risk reduction for progression to symptomatic  @SUBJECT$  can be       achieved with ACE-inhibition  @PREDICAT$  asymptomatic  @OBJECT$  with systolic left       ventricular dysfunction (55).